CYCC.Cyclacel Pharmaceuticals, INC

8-K/A: Bio Green Med Solution Amends 8-K for Logo Correction

Sentiment:

Amendment to Current Report

đź“‹All filings for Cyclacel Pharmaceuticals, INC
đź”’Login to Follow

Bio Green Med Solution, Inc. filed an amended 8-K to correct its corporate logo on the cover page, aligning it with its new name and ticker symbols.

Summary

  • Bio Green Med Solution, Inc. (formerly Cyclacel Pharmaceuticals, Inc.) filed an Amendment No. 1 to its Current Report on Form 8-K.
  • The amendment was filed solely to insert the correct corporate logo on the cover page of the original Form 8-K, which was filed on September 12, 2025.
  • The original Form 8-K had reflected an incorrect new logo for the company.
  • No other changes were made to the content of the Original Form 8-K.
  • The company has updated its logo to coincide with its new name and ticker symbols (BGMS for Common Stock, BGMSP for Preferred Stock) on The Nasdaq Capital Market.

Sentiment

Score: 5

Explanation: The filing is purely administrative, correcting a logo, and has no direct impact on financial performance or strategic direction.

Management Comments

  • Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director, signed the report on behalf of Bio Green Med Solution, Inc.

Industry Context

This administrative filing is specific to Bio Green Med Solution, Inc. and does not reflect broader industry trends or competitive dynamics. It is a routine compliance update to ensure accurate corporate representation in public disclosures.

Stakeholder Impact

  • Shareholders: Provides clarity and accuracy regarding the company's official branding in public filings, ensuring consistent corporate identity.

Key Dates

DateDescription
2025-09-12Date of earliest event reported for the original Form 8-K filing.
2025-09-17Date the Amendment No. 1 to Form 8-K was signed.

Keywords

Bio Green Med Solution, BGMS, SEC filing, 8-K/A, corporate logo, Nasdaq, amendment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.